These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
507 related articles for article (PubMed ID: 23662815)
1. Motivational incentives and methylphenidate enhance electrophysiological correlates of error monitoring in children with attention deficit/hyperactivity disorder. Groom MJ; Liddle EB; Scerif G; Liddle PF; Batty MJ; Liotti M; Hollis CP J Child Psychol Psychiatry; 2013 Aug; 54(8):836-45. PubMed ID: 23662815 [TBL] [Abstract][Full Text] [Related]
2. Effects of motivation and medication on electrophysiological markers of response inhibition in children with attention-deficit/hyperactivity disorder. Groom MJ; Scerif G; Liddle PF; Batty MJ; Liddle EB; Roberts KL; Cahill JD; Liotti M; Hollis C Biol Psychiatry; 2010 Apr; 67(7):624-31. PubMed ID: 19914599 [TBL] [Abstract][Full Text] [Related]
3. Task-related default mode network modulation and inhibitory control in ADHD: effects of motivation and methylphenidate. Liddle EB; Hollis C; Batty MJ; Groom MJ; Totman JJ; Liotti M; Scerif G; Liddle PF J Child Psychol Psychiatry; 2011 Jul; 52(7):761-71. PubMed ID: 21073458 [TBL] [Abstract][Full Text] [Related]
4. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task. Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709 [TBL] [Abstract][Full Text] [Related]
5. Reinforcement and Stimulant Medication Ameliorate Deficient Response Inhibition in Children with Attention-Deficit/Hyperactivity Disorder. Rosch KS; Fosco WD; Pelham WE; Waxmonsky JG; Bubnik MG; Hawk LW J Abnorm Child Psychol; 2016 Feb; 44(2):309-21. PubMed ID: 25985978 [TBL] [Abstract][Full Text] [Related]
6. Electrophysiological effects of stimulant treatment on inhibitory control in children with attention-deficit/hyperactivity disorder. Pliszka SR; Liotti M; Bailey BY; Perez R; Glahn D; Semrud-Clikeman M J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):356-66. PubMed ID: 17630869 [TBL] [Abstract][Full Text] [Related]
7. Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder. Rubia K; Halari R; Mohammad AM; Taylor E; Brammer M Biol Psychiatry; 2011 Aug; 70(3):255-62. PubMed ID: 21664605 [TBL] [Abstract][Full Text] [Related]
8. Effect of methylphenidate on auditory event related potential in boys with attention deficit hyperactivity disorder. Ozdag MF; Yorbik O; Ulas UH; Hamamcioglu K; Vural O Int J Pediatr Otorhinolaryngol; 2004 Oct; 68(10):1267-72. PubMed ID: 15364497 [TBL] [Abstract][Full Text] [Related]
9. Methylphenidate selectively modulates one sub-component of the no-go P3 in pediatric ADHD medication responders. Aasen IE; Øgrim G; Kropotov J; Brunner JF Biol Psychol; 2018 Apr; 134():30-38. PubMed ID: 29476840 [TBL] [Abstract][Full Text] [Related]
10. Electrophysiological investigation of the effectiveness of methylphenidate in children with and without ADHD. Seifert J; Scheuerpflug P; Zillessen KE; Fallgatter A; Warnke A J Neural Transm (Vienna); 2003 Jul; 110(7):821-9. PubMed ID: 12811642 [TBL] [Abstract][Full Text] [Related]
11. First-Dose Methylphenidate-Induced Changes in Brain Functional Connectivity Are Correlated With 3-Month Attention-Deficit/Hyperactivity Disorder Symptom Response. Silberstein RB; Levy F; Pipingas A; Farrow M Biol Psychiatry; 2017 Nov; 82(9):679-686. PubMed ID: 28465019 [TBL] [Abstract][Full Text] [Related]
12. Effects of stimulant medication, incentives, and event rate on reaction time variability in children with ADHD. Epstein JN; Brinkman WB; Froehlich T; Langberg JM; Narad ME; Antonini TN; Shiels K; Simon JO; Altaye M Neuropsychopharmacology; 2011 Apr; 36(5):1060-72. PubMed ID: 21248722 [TBL] [Abstract][Full Text] [Related]
13. Mediators of methylphenidate effects on math performance in children with attention-deficit hyperactivity disorder. Froehlich TE; Antonini TN; Brinkman WB; Langberg JM; Simon JO; Adams R; Fredstrom B; Narad ME; Kingery KM; Altaye M; Matheson H; Tamm L; Epstein JN J Dev Behav Pediatr; 2014; 35(2):100-7. PubMed ID: 24509055 [TBL] [Abstract][Full Text] [Related]
14. Clinically-oriented monitoring of acute effects of methylphenidate on cerebral hemodynamics in ADHD children using fNIRS. Monden Y; Dan H; Nagashima M; Dan I; Kyutoku Y; Okamoto M; Yamagata T; Momoi MY; Watanabe E Clin Neurophysiol; 2012 Jun; 123(6):1147-57. PubMed ID: 22088661 [TBL] [Abstract][Full Text] [Related]
15. Methylphenidate improves some but not all measures of attention, as measured by the TEA-Ch in medication-naïve children with ADHD. Paton K; Hammond P; Barry E; Fitzgerald M; McNicholas F; Kirley A; Robertson IH; Bellgrove MA; Gill M; Johnson KA Child Neuropsychol; 2014; 20(3):303-18. PubMed ID: 23639119 [TBL] [Abstract][Full Text] [Related]
16. Improving working memory in children with attention-deficit/hyperactivity disorder: the separate and combined effects of incentives and stimulant medication. Strand MT; Hawk LW; Bubnik M; Shiels K; Pelham WE; Waxmonsky JG J Abnorm Child Psychol; 2012 Oct; 40(7):1193-207. PubMed ID: 22477205 [TBL] [Abstract][Full Text] [Related]
17. Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder. Bédard AC; Stein MA; Halperin JM; Krone B; Rajwan E; Newcorn JH J Child Psychol Psychiatry; 2015 Jan; 56(1):40-8. PubMed ID: 24942409 [TBL] [Abstract][Full Text] [Related]
18. The ball search field task in the evaluation of methylphenidate treatment of children with attention deficit / hyperactivity disorder. Rosetti MF; Ulloa E; Mayer P; Palacios-Cruz L; de la Peña FR; Hudson R Psychiatry Res; 2020 Nov; 293():113403. PubMed ID: 32835929 [TBL] [Abstract][Full Text] [Related]
19. The influence of methylphenidate on the power spectrum of ADHD children - an MEG study. Wienbruch C; Paul I; Bauer S; Kivelitz H BMC Psychiatry; 2005 Jul; 5():29. PubMed ID: 16042816 [TBL] [Abstract][Full Text] [Related]
20. Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating Scale. Kovshoff H; Banaschewski T; Buitelaar JK; Carucci S; Coghill D; Danckaerts M; Dittmann RW; Falissard B; Grimshaw DG; Hollis C; Inglis S; Konrad K; Liddle E; McCarthy S; Nagy P; Thompson M; Wong IC; Zuddas A; Sonuga-Barke EJ J Child Adolesc Psychopharmacol; 2016 Aug; 26(6):537-47. PubMed ID: 27007169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]